Vir Biotechnology Inc (VIR)
7.34
-0.03
(-0.41%)
USD |
NASDAQ |
Dec 20, 16:00
7.24
-0.10
(-1.36%)
After-Hours: 20:00
Vir Biotechnology Total Liabilities (Quarterly): 257.63M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Janux Therapeutics Inc | 38.92M |
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 33.55M |
| GlycoMimetics Inc | 4.322M |
| FibroGen Inc | 466.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.498B |
| Shareholders Equity (Quarterly) | 1.241B |
| Current Ratio | 8.938 |